大家下午好，我叫高美玉目前，我参与5项临床试验，基本情况分别是1个项目

大家下午好，我叫高美玉<br>目前，我参与5项临床试验，基本情况分别是1个项目处于团队组建阶段，2个项目处于入组期，1个项目处于随访期，1个项目处于清数据阶段。<br>我简单介绍以下两个项目情况：<br>1、天晴3101项目我和照璇一起做，它的适应症是基因ROS1阳性的非小细胞肺癌，合同总中心数是27家，思默负责21家，已经启动中心13家，预筛中心12家。<br>我们目标入组例数95例，目前筛选8例，筛选中3例，筛败1例，入组4例。<br>我们的目标患者比较少，采取措施是：1、CRC提前预筛，储备患者<br>2、科室推荐3、与病理科或其他科室合作4、招募推荐

大家下午好，我叫高美玉<br>目前，我参与5项临床试验，基本情况分别是1个项目处于团队组建阶段，2个项目处于入组期，1个项目处于随访期，1个项目处于清数据阶段。<br>我简单介绍以下两个项目情况：<br>1、天晴3101项目我和照璇一起做，它的适应症是基因ROS1阳性的非小细胞肺癌，合同总中心数是27家，思默负责21家，已经启动中心13家，预筛中心12家。<br>我们目标入组例数95例，目前筛选8例，筛选中3例，筛败1例，入组4例。<br>我们的目标患者比较少，采取措施是：1、CRC提前预筛，储备患者<br>2、科室推荐3、与病理科或其他科室合作4、招募推荐

Good afternoon, everyone. My name is Gao Meiyu<br>At present, I have participated in five clinical trials. The basic situation is that one project is in the stage of team building, two projects are in the stage of group joining, one project is in the stage of follow-up and one project is in the stage of data clearing.<br>I will briefly introduce the following two projects:<br>1. I worked with Zhao Xuan on Tianqing 3101 project. Its indication is non-small cell lung cancer with positive gene ros1. The total number of contract centers is 27, and Simo is responsible for 21. 13 centers have been started and 12 screening centers have been set up.<br>There are 95 cases in the group, 8 cases are screened, 3 cases are screened, 1 case is screened and 4 cases are enrolled.<br>Our target patients are relatively few, and the measures to be taken are: 1. Pre screening of CRC in advance and reserving patients<br>2. Department recommendation 3. Cooperation with pathology department or other departments 4. Recruitment recommendation<br>